Karen Valentine

2020

In 2020, Karen Valentine earned a total compensation of $1.6M as Chief Legal Officer and General Counsel at CONSTELLATION PHARMACEUTICALS.

Compensation breakdown

Non-Equity Incentive Plan$143,520
Option Awards$1,057,937
Salary$377,681
Other$14,725
Total$1,593,863

Valentine received $1.1M in option awards, accounting for 66% of the total pay in 2020.

Valentine also received $143.5K in non-equity incentive plan, $377.7K in salary and $14.7K in other compensation.

Rankings

In 2020, Karen Valentine's compensation ranked 6,571st out of 13,090 executives tracked by ExecPay. In other words, Valentine earned more than 49.8% of executives.

ClassificationRankingPercentile
All
6,571
out of 13,090
50th
Division
Manufacturing
2,720
out of 5,621
52nd
Major group
Chemicals And Allied Products
1,096
out of 2,254
51st
Industry group
Drugs
950
out of 1,954
51st
Industry
Pharmaceutical Preparations
710
out of 1,459
51st
Source: SEC filing on April 23, 2021.

Valentine's colleagues

We found four more compensation records of executives who worked with Karen Valentine at CONSTELLATION PHARMACEUTICALS in 2020.

2020

Jigar Raythatha

CONSTELLATION PHARMACEUTICALS

Chief Executive Officer

2020

Jeffrey Humphrey

CONSTELLATION PHARMACEUTICALS

Chief Medical Officer

2020

Emma Reeve

CONSTELLATION PHARMACEUTICALS

Chief Financial Officer

2020

Patrick Trojer

CONSTELLATION PHARMACEUTICALS

Chief Scientific Officer

News

In-depth

You may also like